Our Business
Novartis focuses its business on three divisions: pharmaceuticals, eye care and generics. These three divisions are supported by our research organization, the Novartis Institutes for BioMedical Research (NIBR), and a centralized services group, Novartis Business Services, to facilitate collaboration across our divisions, and drive efficiency and productivity gains.
We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.
Innovative Medicines
Our global portfolio of innovative patented medicines includes more than 50 key marketed products, many of which are the leaders in their therapeutic areas.
Generics Medicines and Biosimilars
Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1,000 different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers new ways to help people around the world access high quality medicines.
Eye Care Devices
The Alcon Division provides innovative products that enhance quality of life by helping people worldwide see better. Its Surgical and Vision Care businesses offer a wide spectrum of eye care products.
Novartis in Ireland
Novartis is one of Ireland’s leading employers in the healthcare industry with a strong history of investing in Ireland since the 1950's.
Manufacturing
Novartis has two manufacturing presences in Ireland. Novartis Ringaskiddy and Alcon, both in Cork.